Profile

Dan O'Leary, CQA, CQE

Contact Details

United States

Contributions

1 to 5 of 50+ total
Posted By Dan O'Leary 07-May-2024 10:20
Found In Egroup: Regulatory Open Forum
\ view thread
It is important to distinguish among three concepts; identification, tracking, and tracing. They are different, but may have some overlap. In the US system: Identification tells us what the device is Tracing provides information about critical devices and their components Tracking provides information ...
Posted By Dan O'Leary 06-May-2024 11:54
Found In Egroup: Regulatory Open Forum
\ view thread
I'll address the first question only. You need to be very cautious with the phrase "Research Use Only" in the context of medical devices (IVDs) in the US. RUO has two meanings. One is reagents not intended for use in humans. For example, your company might sell reagents with the intention of research ...
Posted By Dan O'Leary 02-May-2024 17:16
Found In Egroup: Regulatory Open Forum
\ view thread
If something happened to an end user and you learned about it, then you will initiate a complaint under 820.198. The complaint triggers an investigation to determine if it is reportable as a Medical Device Report, MDR, under Part 803. From the brief description, I would expect it is reportable. You ...
Posted By Dan O'Leary 01-May-2024 13:02
Found In Egroup: Regulatory Open Forum
\ view thread
Attached ------------------------------ Dan O'Leary CQA, CQE Swanzey NH United States ------------------------------
Posted By Dan O'Leary 01-May-2024 13:02
Found In Library: Regulatory Open Forum